“…32,33,37 Despite data that telemedicine could increase access to vascular surgical services, reduce in-person outpatient attendance, reduce non-attendance rates, reduce both patient and hospital costs, and ensure that those patients who did require in-person consultations had sufficient dedicated time, all while maintaining patient satisfaction, adoption rates for telemedicine was low overall, in part due to the absence of relevant legislative and reimbursement protocols. 32,33,37 Nonetheless, in the years immediately prior to the COVID-19 pandemic, the development and implementation of telemedicine clinics was increasingly reported. In vascular surgery, the use of telemedicine in the management of patients with chronic venous ulcers, diabetic ulcers, peripheral arterial disease and chronic venous insufficiency had been reported.…”